- 3115 Chamber St #3 Venus, Tx. HRS 9am-5pm CST M-F
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the effects of the body’s natural GLP-1 hormone, which regulates blood sugar levels, slows gastric emptying, and suppresses appetite. It is commonly used for type 2 diabetes management and weight loss in individuals with or without diabetes.
Vitamin B6 (Pyridoxine) is an essential water-soluble vitamin involved in numerous biochemical processes, including amino acid metabolism, neurotransmitter synthesis (such as serotonin and dopamine), and immune function. It also plays a role in reducing nausea and supporting energy metabolism.
When combined in an injectable form, the formulation leverages the metabolic and appetite-suppressing effects of Semaglutide, while B6 supports, energy, and digestive comfort.
1. Enhanced Weight Management – Semaglutide suppresses appetite and promotes satiety while B6 supports metabolic processes and energy production, complementing the effects of weight loss.
2. Improved Glycemic Control – Semaglutide helps lower HbA1c and fasting glucose levels while B6 may assist in glucose metabolism and reduce diabetic neuropathy risk.
3. Reduced Nausea and GI Side Effects – A common side effect of GLP-1 agonists is nausea. Vitamin B6 is well known for its anti-nausea properties, especially in therapeutic doses, which can help mitigate this side effect.
4. Mood and Cognitive Support – B6 Supports neurotransmitter synthesis, which may improve mood, focus, and reduce anxiety– especially useful during periods of calorie restriction.
5. Enhanced Patient Tolerance and Compliance – The addition of B6 can improve tolerability of Semaglutide, making patients more likely to continue therapy long-term.
2.5mg/50mg/1mL (Seal Color: Magenta)
5mg/100mg/2mL (Seal Color: Grey)
10mg/200mg/4mL (Seal Color: White)
Dosing Guide:
0.25mg (0.1ML or 10 units on an insulin syringe) Sub-Q once a week
0.5mg (0.2ML or 20 units on an insulin syringe) Sub-Q once a week
0.75mg (0.3ML or 30 units on an insulin syringe) Sub-Q once a week
1mg (0.4ML or 40 units on an insulin syringe) Sub-Q once a week
1.25mg (0.5ML or 50 units on an insulin syringe) Sub-Q once a week
1.5mg (0.6ML or 60 units on an insulin syringe) Sub-Q once a week
1.75mg (0.7ML or 70 units on an insulin syringe) Sub-Q once a week
2mg (0.8ML or 80 units on an insulin syringe) Sub-Q once a week
2.4mg (0.96ML or 96 units on an insulin syringe) Sub-Q once a week
*Keep Refrigerated*
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It enhances insulin secretion, reduces glucagon levels, slows gastric emptying, and significantly reduces appetite. It is FDA-approved for type 2 diabetes management and has shown powerful weight loss effects.
Vitamin B6 (Pyridoxine) is an essential water-soluble vitamin involved in numerous biochemical processes, including amino acid metabolism, neurotransmitter synthesis (such as serotonin and dopamine), and immune function. It also plays a role in reducing nausea and supporting energy metabolism.
1. Potent Weight Loss Support – Tirzepatide targets both GIP and GLP-1 pathways, leading to enhanced appetite suppression, improved insulin sensitivity, and greater fat loss, while B6 assists by supporting metabolic function and energy production, which is helpful during caloric restriction.
2. Reduced Nausea and GI Tolerance – One of the main drawbacks of GLP-1/GIP therapy is nausea and gastrointestinal discomfort. Vitamin B6 has well-established anti-nausea effects, commonly used in pregnancy and chemotherapy patients, making it ideal to offset GI side effects from Tirzepatide.
3. Improved Mood and Cognitive Support – B6 promotes serotonin and dopamine production, which can stabilize mood and reduce fatigue or irritability.
4. Better Patient Compliance – Improved tolerance and mood support can help patients stay consistent with their treatment protocol, maximizing long-term outcomes.
5. Metabolic and Hormonal Balance – B6 supports healthy hormone function and metabolic enzyme activity, complementing the insulin-regulating effects of Tirzepatide.
15mg/25mg/1mL (Seal Color: Blue)
30mg/50mg/2mL (Seal Color: Green)
60mg/100mg/4mL (Seal Color: Red)
Dosing Guide:
2.5mg (0.17ML or 17 units on an insulin syringe) Sub-Q once a week
5mg (0.34ML or 34 units on an insulin syringe) Sub-Q once a week
7.5mg (0.50ML or 50 units on an insulin syringe) Sub-Q once a week
10mg (0.67ML or 67 units on an insulin syringe) Sub-Q once a week
12.5mg (0.84ML or 84 units on an insulin syringe) Sub-Q once a week
15mg (1ML or 100 units on an insulin syringe) Sub-Q once a week
*Keep Refrigerated*